Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Acute candesartan cilexetil outcomes stroke trial (ACCOST)

Trial Profile

Acute candesartan cilexetil outcomes stroke trial (ACCOST)

Completed
Phase of Trial: Phase IV

Latest Information Update: 17 Jan 2017

At a glance

  • Drugs Candesartan cilexetil (Primary)
  • Indications Stroke
  • Focus Therapeutic Use
  • Acronyms ACCOST
  • Most Recent Events

    • 07 Oct 2009 Actual end date (Jun 2006) added as reported by ISRCTN: Current Controlled Trials.
    • 07 Oct 2009 Additional lead trial centres and investigators identified as reported by ISRCTN: Current Controlled Trials.
    • 07 Oct 2009 Status changed from active, no longer recruiting to completed as reported by ISRCTN: Current Controlled Trials.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top